Darotropium | 850689-51-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Darotropium
• 英文别名: 3-[(1R,5S)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl]-2,2-diphenylpropanenitrile
• CAS: 850689-51-9
• 化学式: C24H29N2+
• 分子量: 345.5
• InChiKey: BKLAJZNVMHLXAP-VKGMXUHCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• INHALATION COMPOSITIONS COMPRISING MUSCARINIC RECEPTOR ANTAGONIST
  申请人：Arven Ilac Sanayi Ve Ticaret A.S.

  公开号：US20150157567A1

  公开（公告）日：2015-06-11

  The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and the desired stability used in inhaler devices.
• COMPOSITIONS COMPRISING MUSCARINIC RECEPTOR ANTAGONIST AND GLUCOSE ANHYDROUS
  申请人：Arven llac Sanayi Ve Ticaret A.S.

  公开号：US20150174064A1

  公开（公告）日：2015-06-25

  The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and the desired stability used in inhaler devices.
• COMPOSITIONS COMPRISING MUSCARINIC RECEPTOR ANTAGONIST AND SORBITOL
  申请人：Arven llac Sanayi Ve Ticaret A.S.

  公开号：US20150165038A1

  公开（公告）日：2015-06-18

  The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and the desired stability used in inhaler devices.